Cargando…

Moving the needle for COVID-19 vaccinations in Nigeria through leadership, accountability, and transparency

BACKGROUND: The first set of vaccines arrived in Nigeria in March 2021. The National Primary Health Care Development Agency (NPHCDA) set out to vaccinate at least 70% percent of Nigeria’s eligible population, i.e., 111,776,503 people, by December 2022. As of June 2021, only 3% had received at least...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojeniyi, Toluwanimi, Eguavoen, Amenze, Chinye-Nwoko, Fejiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552183/
https://www.ncbi.nlm.nih.gov/pubmed/37808977
http://dx.doi.org/10.3389/fpubh.2023.1199481
_version_ 1785115905356726272
author Ojeniyi, Toluwanimi
Eguavoen, Amenze
Chinye-Nwoko, Fejiro
author_facet Ojeniyi, Toluwanimi
Eguavoen, Amenze
Chinye-Nwoko, Fejiro
author_sort Ojeniyi, Toluwanimi
collection PubMed
description BACKGROUND: The first set of vaccines arrived in Nigeria in March 2021. The National Primary Health Care Development Agency (NPHCDA) set out to vaccinate at least 70% percent of Nigeria’s eligible population, i.e., 111,776,503 people, by December 2022. As of June 2021, only 3% had received at least one dose of the vaccine. This presented a threat to the achievement of NPHCDA’s goal. Nigeria Solidarity Support Fund (NSSF) went into a partnership with NPHCDA to accelerate the uptake of COVID-19 vaccinations across Nigeria over 3 months. METHODS: Across Nigeria’s 6 geopolitical zones, 6 states were selected, namely: Adamawa, Edo, Imo, Katsina, Nasarawa, and Ogun states based on performance, political will, and absence of external resources. A two-pronged approach was implemented: unrestricted funding to the sub-national level and providing technical support at the national level. RESULTS: 5 out of 6 states received unrestricted funding to ramp up vaccination coverage. They also received adequate vaccine supplies. A total of 12,000 healthcare workers were trained on safe immunization practices and multiple communities were engaged across the 133 local government areas (LGAs) through religious and community leaders. After 6 months, there was an average of 35% increase in the uptake of COVID-19 vaccines in the 5 states. An indicator tracker was developed for weekly reviews at the national level and the total population vaccinated in Nigeria increased from 6,186,647 to 11,985,336 at the end of the partnership. CONCLUSION: Unrestricted funding, though not without its risks, can yield a significant impact on health. The intervention was co-designed with stakeholders and had leadership buy-in, accountability mechanisms, with unrestricted funding. These techniques produced an increase in the vaccination rates in the 5 states and across the country. These elements should be explored for application to other program designs such as routine immunization.
format Online
Article
Text
id pubmed-10552183
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105521832023-10-06 Moving the needle for COVID-19 vaccinations in Nigeria through leadership, accountability, and transparency Ojeniyi, Toluwanimi Eguavoen, Amenze Chinye-Nwoko, Fejiro Front Public Health Public Health BACKGROUND: The first set of vaccines arrived in Nigeria in March 2021. The National Primary Health Care Development Agency (NPHCDA) set out to vaccinate at least 70% percent of Nigeria’s eligible population, i.e., 111,776,503 people, by December 2022. As of June 2021, only 3% had received at least one dose of the vaccine. This presented a threat to the achievement of NPHCDA’s goal. Nigeria Solidarity Support Fund (NSSF) went into a partnership with NPHCDA to accelerate the uptake of COVID-19 vaccinations across Nigeria over 3 months. METHODS: Across Nigeria’s 6 geopolitical zones, 6 states were selected, namely: Adamawa, Edo, Imo, Katsina, Nasarawa, and Ogun states based on performance, political will, and absence of external resources. A two-pronged approach was implemented: unrestricted funding to the sub-national level and providing technical support at the national level. RESULTS: 5 out of 6 states received unrestricted funding to ramp up vaccination coverage. They also received adequate vaccine supplies. A total of 12,000 healthcare workers were trained on safe immunization practices and multiple communities were engaged across the 133 local government areas (LGAs) through religious and community leaders. After 6 months, there was an average of 35% increase in the uptake of COVID-19 vaccines in the 5 states. An indicator tracker was developed for weekly reviews at the national level and the total population vaccinated in Nigeria increased from 6,186,647 to 11,985,336 at the end of the partnership. CONCLUSION: Unrestricted funding, though not without its risks, can yield a significant impact on health. The intervention was co-designed with stakeholders and had leadership buy-in, accountability mechanisms, with unrestricted funding. These techniques produced an increase in the vaccination rates in the 5 states and across the country. These elements should be explored for application to other program designs such as routine immunization. Frontiers Media S.A. 2023-09-21 /pmc/articles/PMC10552183/ /pubmed/37808977 http://dx.doi.org/10.3389/fpubh.2023.1199481 Text en Copyright © 2023 Ojeniyi, Eguavoen and Chinye-Nwoko. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Ojeniyi, Toluwanimi
Eguavoen, Amenze
Chinye-Nwoko, Fejiro
Moving the needle for COVID-19 vaccinations in Nigeria through leadership, accountability, and transparency
title Moving the needle for COVID-19 vaccinations in Nigeria through leadership, accountability, and transparency
title_full Moving the needle for COVID-19 vaccinations in Nigeria through leadership, accountability, and transparency
title_fullStr Moving the needle for COVID-19 vaccinations in Nigeria through leadership, accountability, and transparency
title_full_unstemmed Moving the needle for COVID-19 vaccinations in Nigeria through leadership, accountability, and transparency
title_short Moving the needle for COVID-19 vaccinations in Nigeria through leadership, accountability, and transparency
title_sort moving the needle for covid-19 vaccinations in nigeria through leadership, accountability, and transparency
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552183/
https://www.ncbi.nlm.nih.gov/pubmed/37808977
http://dx.doi.org/10.3389/fpubh.2023.1199481
work_keys_str_mv AT ojeniyitoluwanimi movingtheneedleforcovid19vaccinationsinnigeriathroughleadershipaccountabilityandtransparency
AT eguavoenamenze movingtheneedleforcovid19vaccinationsinnigeriathroughleadershipaccountabilityandtransparency
AT chinyenwokofejiro movingtheneedleforcovid19vaccinationsinnigeriathroughleadershipaccountabilityandtransparency